These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 10676586)

  • 21. The value of specifying brand-name antiepileptic drugs.
    Ng YT
    Arch Neurol; 2009 Nov; 66(11):1415-6. PubMed ID: 19901176
    [No Abstract]   [Full Text] [Related]  

  • 22. Generic substitution of antiepileptic drugs--a survey of patients' perspectives in Germany and other German-speaking countries.
    Hensler K; Uhlmann C; Porschen T; Benecke R; Rösche J
    Epilepsy Behav; 2013 Apr; 27(1):135-9. PubMed ID: 23416284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.
    Kesselheim AS; Stedman MR; Bubrick EJ; Gagne JJ; Misono AS; Lee JL; Brookhart MA; Avorn J; Shrank WH
    Drugs; 2010 Mar; 70(5):605-21. PubMed ID: 20329806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Requirements for generic antiepileptic medicines: a clinical perspective.
    Trinka E; Krämer G; Graf M
    J Neurol; 2011 Dec; 258(12):2128-32. PubMed ID: 21667222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current approaches to the use of generic antiepileptic drugs.
    Krämer G; Biraben A; Carreno M; Guekht A; de Haan GJ; Jedrzejczak J; Josephs D; van Rijckevorsel K; Zaccara G
    Epilepsy Behav; 2007 Aug; 11(1):46-52. PubMed ID: 17537678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrapatient variation in antiepileptic drug plasma concentration after generic substitution vs stable brand-name drug regimens.
    Contin M; Alberghini L; Candela C; Benini G; Riva R
    Epilepsy Res; 2016 May; 122():79-83. PubMed ID: 26987080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patient perception of generic antiepileptic drugs in the Midwestern United States.
    Papsdorf TB; Ablah E; Ram S; Sadler T; Liow K
    Epilepsy Behav; 2009 Jan; 14(1):150-3. PubMed ID: 18845274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effectiveness of generic versus brand-name antiepileptic medications.
    Gagne JJ; Kesselheim AS; Choudhry NK; Polinski JM; Hutchins D; Matlin OS; Brennan TA; Avorn J; Shrank WH
    Epilepsy Behav; 2015 Nov; 52(Pt A):14-8. PubMed ID: 26386779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of generic antiepileptic drugs in the treatment of childhood epilepsy].
    Campos-Castelló J
    Medicina (B Aires); 2009; 69(1 Pt 1):109-13. PubMed ID: 19240008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of generic medication in epilepsy: a review of potential issues and challenges.
    Van Paesschen W; Hauman H; Lagae L
    Eur J Paediatr Neurol; 2009 Mar; 13(2):87-92. PubMed ID: 18790656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brand name to generic substitution of levetiracetam in patients with epilepsy.
    Gha-Hyun L; Dae SJ
    Seizure; 2018 Aug; 60():127-131. PubMed ID: 29960217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing bioequivalence of generic antiepilepsy drugs.
    Krauss GL; Caffo B; Chang YT; Hendrix CW; Chuang K
    Ann Neurol; 2011 Aug; 70(2):221-8. PubMed ID: 21717495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generic substitution of antiepileptic drugs: a systematic review of prospective and retrospective studies.
    Yamada M; Welty TE
    Ann Pharmacother; 2011 Nov; 45(11):1406-15. PubMed ID: 22028417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of antiepileptic drugs to generic brittleness in patients with epilepsy.
    Das S; Jiang X; Jiang W; Ting TY; Polli JE
    Epilepsy Behav; 2020 Apr; 105():106936. PubMed ID: 32092462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brand-to-generic levetiracetam switch in patients with epilepsy in a routine clinical setting.
    Markoula S; Chatzistefanidis D; Gatzonis S; Siatouni A; Siarava E; Verentzioti A; Kyritsis AP; Patsalos PN
    Seizure; 2017 May; 48():1-6. PubMed ID: 28363098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic impact of generic substitution of lamotrigine: projected costs in the US using findings in a Canadian setting.
    LeLorier J; Duh MS; Paradis PE; Latrémouille-Viau D; Lefebvre P; Manjunath R; Sheehy O
    Curr Med Res Opin; 2008 Apr; 24(4):1069-81. PubMed ID: 18315941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are generic drugs really inferior medicines?
    Moore N; Berdaï D; Bégaud B
    Clin Pharmacol Ther; 2010 Sep; 88(3):302-4. PubMed ID: 20725079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioequivalence of antiepileptic drugs: how close is close enough?
    Gidal BE
    Curr Neurol Neurosci Rep; 2009 Jul; 9(4):333-7. PubMed ID: 19515287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of generic switching on concerns about medicine and non-persistence among Danish adults in a general practice setting.
    Rathe JØ
    Dan Med J; 2015 Oct; 62(10):B5148. PubMed ID: 26441397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Generic drugs in the treatment of epilepsy].
    González de Dios J; Ochoa-Sangrador C; Sempere AP
    Rev Neurol; 2005 Dec 1-15; 41(11):676-83. PubMed ID: 16317637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.